Patents by Inventor Mingzhu FAN

Mingzhu FAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
    Patent number: 10968188
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 6, 2021
    Assignee: 1st Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, A Yeong Park, Gwibin Lee, Jae Eun Kim, Misoon Kim, Gyooseung Jung, Seung Mook Lim, Keonseung Lim, Minwoo Lee, Heekyoung Yang, Hyonam Kim, Hyeongjun Kim, Wanjun Li, Mingzhu Fan
  • BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20200270222
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: May 14, 2020
    Publication date: August 27, 2020
    Inventors: Jinhwa LEE, Suyeon JO, A Yeong PARK, Gwibin LEE, Jae Eun KIM, Misoon KIM, Gyooseung JUNG, Seung Mook LIM, Keonseung LIM, Minwoo LEE, Heekyoung YANG, Hyonam KIM, Hyeongjun KIM, Wanjun LI, Mingzhu FAN
  • Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
    Patent number: 10669246
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: June 2, 2020
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Gwibin Lee, Keonseung Lim, A Yeong Park, Wanjun Li, Mingzhu Fan
  • BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20190100500
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: October 1, 2018
    Publication date: April 4, 2019
    Inventors: Jinhwa LEE, Jae Eun KIM, Suyeon JO, Gwibin LEE, Keonseung LIM, A Yeong PARK, Misoon KIM, Gyooseung JUNG, Seung Mook LIM, Minwoo LEE, Heekyoung YANG, Hyonam KIM, Hyeongjun KIM, Wanjun LI, Mingzhu FAN